Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q1 2024 Earnings Conference Call May 15, 2024 8:00 AM ET
Company Participants
Robert Shawah - CFO
David Luci - President and CEO
Robert DeLuccia - Executive Chairman
Conference Call Participants
Ed Arce - H.C. Wainwright
James Molloy - Alliance Global Partners
Operator
Hello, and welcome to the Acurx Pharmaceuticals First Quarter 2024 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
It's now my pleasure to turn the conference over to CFO, Robert Shawah. Please go ahead.
Robert Shawah
Thank you, Kevin. Good morning, and welcome to our call. This morning we issued a press release providing financial results and company highlights for the first quarter of 2024, which is available on our website at acurxpharma.com.
Joining me today is Dave Luci, President and CEO of Acurx, who will give a corporate update and outlook, as well as our Executive Chairman, Bob DeLuccia. After that, I'll provide some highlights of the financials from the quarter ended March 31, 2024, then turn the call back over to Dave and Bob for their closing remarks.
As a reminder, during today's call, we'll be making certain forward-looking statements. These forward looking statements are based on current information, assumptions, estimates and projections about future events that are subject to change and involve a number of risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements.
Investors should consider these risks and other information described in our filings made with the Securities and Exchange Commission, including our quarterly report on Form 10-Q, which we filed on Tuesday, May 14, 2024. You are cautioned not to place undue reliance on these forward-looking statements and Acurx disclaims any obligation to update such statements at any time in the future. This conference call contains time-sensitive information
- Read more current ACXP analysis and news
- View all earnings call transcripts